Biomarker Evolution in Pediatric SMA: Insights from CSF pNF-H Dynamics and SMN2 Copy Number During Nusinersen Therapy
Spinal muscular atrophy (SMA) is a severe neurodegenerative disorder caused by insufficient survival motor neuron (SMN) protein synthesis, leading to progressive motor neuron loss and debilitating symptoms. This study evaluates cerebrospinal fluid (CSF) phosphorylated neurofilament-heavy chain (pNF-...
Saved in:
| Main Authors: | Mihaela Badina, Gabriel Cristian Bejan, Andrada Mirea, Corina Sporea, Madalina Cristina Leanca, Georgiana Nicolae, Ioana Elena Cioca, Maria Veronica Morcov, Angelo Pellegrini, Elena-Nicoleta Bordea |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Romanian Association of Balneology, Editura Balneara
2025-03-01
|
| Series: | Balneo and PRM Research Journal |
| Subjects: | |
| Online Access: | https://bioclima.ro/Balneo777.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H
by: Mihaela Badina, et al.
Published: (2025-12-01) -
Predictive Clinical-Biological Markers Over the First 3 Years of Nusinersen Treatment in SMA Type 1 Patients
by: Mihaela Badina, et al.
Published: (2025-12-01) -
The efficacy and safety of nusinersen within the expanded access program in Russia
by: S. B. Artemieva, et al.
Published: (2020-12-01) -
Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment
by: Yiğithan Güzin, et al.
Published: (2024-11-01) -
Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers
by: Yifan Sun, et al.
Published: (2025-04-01)